Skip to main content
Log in

Mycophenolate mofetil could be worth it in lupus nephritis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Tse KC, Tang CSO, Lam MF, Yap DYH, Chan TM.Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis. The Journal of Rheumatology 36: 76-81, No. 1, Jan 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mycophenolate mofetil could be worth it in lupus nephritis. Pharmacoecon. Outcomes News 573, 9 (2009). https://doi.org/10.2165/00151234-200905730-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905730-00028

Keywords

Navigation